THINKCYTE LOGO

News

News

ThinkCyte Launches New Website and Showcases VisionSort at Global Events

May 16, 2024

Events

ThinkCyte to Exhibit at ARVO 2024

Apr 29, 2024

Events

ThinkCyte to Exhibit at AAI 2024

Apr 29, 2024

Events

ThinkCyte to Showcase VisionSort at CYTO 2024

Apr 5, 2024

News

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

Apr 1, 2024

Events

ThinkCyte to Attend the 2024 Association of Biomolecular Resource Facilities (ABRF) Annual Meeting

Mar 28, 2024

Events

ThinkCyte to Attend SoCal Flow SUMMIT 2024

Mar 28, 2024

Events

ThinkCyte to Showcase VisionSort at the 2024 American Association for Cancer Research (AACR) Annual Meeting

Mar 28, 2024

News

ThinkCyte collaborates with joint research group to advance development of stem cell-based therapies

Jan 23, 2024

Events

ThinkCyte to Present VisionSort Applications in Drug Screening at the 2024 Society for Laboratory Automation and Screening (SLAS) Annual Meeting

Jan 19, 2024

News

ThinkCyte Launches Partnering Platform

Jan 9, 2024

News

ThinkCyte Secures $24 million in Funding to Accelerate Growth

Nov 28, 2023

News

ThinkCyte and FIMM Establish Research Partnership to Advance Understanding and Treatment of Blood Cancer

Jul 17, 2023

News

Juntendo University, Sysmex, and ThinkCyte collaborate to advance the early detection and treatment of blood cancer

Apr 17, 2023

News

ThinkCyte primed for continued growth as it expands with new Bay Area headquarters

Apr 10, 2023

Events

ThinkCyte to Showcase VisionSort at the 2023 American Association for Cancer Research (AACR) Annual Meeting

Apr 6, 2023

News

ThinkCyte reveals VisionSort™, the world’s first dual mode, AI-driven cell characterization and sorting platform.

Mar 3, 2023

Events

ThinkCyte to Debut VisionSort at the 2023 Society for Laboratory Automation and Screening (SLAS) International Conference and Exhibition

Feb 13, 2023

News

ThinkCyte broadens Advisory Board with the appointments of Dr. Diether Recktenwald, Ph.D. and Dr. Bo Saxberg, M.D. Ph.D.

Jan 23, 2023

News

ThinkCyte and Axcelead DDP collaborate to advance novel phenotypic drug screening methods

Dec 26, 2022

News

PhoreMost and ThinkCyte collaborate to advance AI-based drug discovery

Dec 13, 2022

Events

ThinkCyte to Showcase Ghost Cytometry at the 64th ASH Annual Meeting and Exposition

Dec 6, 2022

News

Vision Care Group and ThinkCyte Announce Research Alliance in Advanced Cell Therapy

Dec 6, 2022

News

ThinkCyte announces Premier Early Access Program for its new label-free cell characterization and sorting system

Jul 21, 2022

News

ThinkCyte shares applications of Ghost Cytometry with industrial and academic thought leaders

Jul 11, 2022

News

ThinkCyte Establishes Presence in the Bay Area and Strengthens Senior Management Team With Industry Veteran

Jun 23, 2022

News

ThinkCyte’s novel label-free in-silico ghost cytometry published in eLife

Dec 21, 2021

News

ThinkCyte Secures $26 Million in Series B Financing

May 19, 2021

News

Sysmex and ThinkCyte Agree on Joint Development and Capital Alliance

May 12, 2021

News

ThinkCyte Awarded NEDO PCA Grant to Advance Label-free Cell Sorting Technology for Cell Therapy

Aug 24, 2020

News

ThinkCyte and National Cancer Center Japan Jointly Awarded AMED Grant for Isolation of Circulating Tumor Cells

Jul 9, 2020

News

Hitachi and ThinkCyte Announce Collaboration to Develop an AI-driven Cell Analysis and Sorting System

Jul 1, 2020

News

ThinkCyte Completes $15 Million Series A Financing

May 29, 2020

News

ThinkCyte Selected for J-Startup Program

Jun 24, 2019

News

ThinkCyte Graduated Berkeley SkyDeck Cohort Program

Dec 20, 2018

News

ThinkCyte Selected for the Inaugural Class of Google Launchpad Accelerator Tokyo

Nov 1, 2018

News

ThinkCyte Publishes Paper on “Ghost Cytometry” Method in Science

Jun 15, 2018

News

ThinkCyte Completes Seed Financing

Jun 15, 2018